A Targeted, Real-Time, Technology-Supported Intervention for Patients With Alcohol Use Disorder on Disulfiram

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 29, 2018

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions
Drinking, Alcohol
Interventions
BEHAVIORAL

Wisepill+SMS

This will include: 1) an in-person Wisepill orientation session to introduce the pillbox and generate relapse prevention messages that can be later delivered during non-adherent windows; 2) use of the Wisepill device during the intensive treatment program and after discharge; and 3) three forms of tailored SMS messages paired with Wisepill device use: a) supportive messages with medication compliance, b) reminder messages for early non-adherence (e.g., 1 hour late) and c) relapse-prevention messages after longer periods of non-adherence (e.g., several hours).

OTHER

Wisepill-only

This will include: 1) an in-person Wisepill orientation session to introduce the pillbox; 2) use of the Wisepill during the intensive treatment program and after discharge.

Trial Locations (1)

02906

Butler Hospital, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Butler Hospital

OTHER

NCT03543735 - A Targeted, Real-Time, Technology-Supported Intervention for Patients With Alcohol Use Disorder on Disulfiram | Biotech Hunter | Biotech Hunter